Heron Therapeutics, Inc.

Q2 2024 13F Holders

Symbol
HRTX
CUSIP
427746102
Type
Equity
Class
COM
Num filings
197
Total reported value, excl. options
$457 M
Manager Report Date Value ($000) Shares Option Type